Feb 05, 2019
Cellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellect's ApoGraft(TM) for Bone Marrow Transplantations
Jan 28, 2019
Completion of Manufacturing of Clinical Grade FasL Enables Cellect to Expedite U.S. Clinical Programs into Multiple Studies
Jan 23, 2019
Cellect Biotechnology Reports Clinical and Regulatory Milestone Targets
Dec 17, 2018
Further to the Announcement of the Agreement Signed With the South Korean Cell2in: KORIL Approves Cellect's Grant Application
Nov 13, 2018
Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results
Nov 05, 2018
Cellect Receives Multiple Patent Grants
Nov 01, 2018
Cellect to Present Its Breakthrough Stem Cell Production Technology at the BIO-Europe
Oct 22, 2018
Cellect Announces a Major Technological Breakthrough for Industrialization of Apotainer(TM) Stem Cell Product Line
Oct 18, 2018
Positive Results of Orthopedic Treatment With the Use of ApoGraft(TM) Enriched Stem Cells Derived From Fat Tissues
Oct 15, 2018
Cellect Announces Positive Clinical Results
Aug 20, 2018
Cellect Receives Notice of Allowance for Stem Cell Selection Technology Patent in Korea
Aug 09, 2018
Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2018 Financial Results
Aug 07, 2018
Cellect Granted Key European Patent for Its Stem Cell Selection Technology
Jul 09, 2018
Cellect Signed Strategic Agreement with Swiss Biotech Center (SBC)
Jul 05, 2018
Cellect Signs Collaboration Agreement With Dresden University denovoMATRIX Team
Jun 04, 2018
Frost & Sullivan Publishes Annual 2017, Q1-2018 And 12 Mos. Since Initiation Updates On Cellect Biotechnology Ltd.
May 17, 2018
Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial Results
May 10, 2018
Former GE Healthcare Executive to Join Cellect as Chief Business Officer
Apr 09, 2018
Cellect Announces a Major Milestone for Enabling Stem Cells Production
Mar 19, 2018
Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results